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Abstract: Zinc chloride is an important pharmaceutical/nutraceutical mineral for the prevention and treatment of several 
diseases. The objective of the current study was to investigate the impact of The Trivedi Effect®-Energy of Consciousness 
Healing Treatment (Biofield Energy Treatment) on physical, structural, thermal, and behavioral properties of zinc chloride 
using PXRD, PSD, FT-IR, UV-vis, and DSC analysis. Zinc chloride was divided into two parts – one part was control, while 
another part was treated with The Trivedi Effect® remotely by seven renowned Biofield Energy Healers and defined as The 
Trivedi Effect® treated sample. A significant alteration of the crystallite size and relative intensities of the PXRD peaks were 
observed in The Trivedi Effect® treated sample with respect to the control sample. A sharp peak at 2θ equal to 51.45°, which 
was observed in the control sample was disappeared in the treated sample. The average crystallite size of the treated sample 
was decreased by 2.13% compared with the control sample. The size of the particles at d10, d50, and d90 was decreased by 
3.36%, 7.97%, and 11.51%, respectively in the treated sample compared with the control sample. The surface area of the 
treated sample was significantly increased by 5.69% compared with the control sample. The FT-IR spectroscopic analysis 
revealed that Zn-Cl stretching in the control was 646 cm-1, whereas it was significantly shifted downward to 505 cm-1in the 
treated sample. The UV-vis analysis exhibited that wavelength of the maximum absorbance (λmax) of both the control and 
treated samples was at 196.4 nm. The DSC analysis exhibited that the melting and decomposition temperature were increased 
by 0.93% and 0.56%, respectively in the treated zinc chloride compared to the control sample. The enthalpy of fusion of the 
treated sample (338.27 J/g) was increased significantly by 33.84% compared with the control sample (252.75 J/g). The 
enthalpy of decomposition of the treated sample was increased by 3.78% compared with the control sample. The current study 
anticipated that The Trivedi Effect®-Energy of Consciousness Healing Treatment might lead to produce a new polymorphic 
form of zinc chloride, which would be more soluble, bioavailable, and thermally stable compared with the untreated 
compound. The treated sample could be more stable during manufacturing, delivery or storage conditions than the untreated 
sample. Hence, the treated zinc chloride would be very useful to design better nutraceutical/pharmaceutical formulations that 
might offer better therapeutic response against inflammatory diseases, immunological disorders, aging, stress, cancer, etc. 
Keywords: Biofield Energy Healing Treatment, Consciousness Energy Healing Treatment, Biofield Energy Healers,  
The Trivedi Effect®, Zinc Chloride, PXRD, Particle Size, DSC 
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1. Introduction 
Zinc is an essential element in human and animal nutrition for 
its broad spectrum of biological activities. It plays an important 
role in catalytic, structural or regulation in enzymes in our body, 
which involved in the nucleic acid and protein metabolism as 
well as for the production of energy. Zinc also maintains the 
structural integrity of the biological membranes resulting in their 
protection against oxidative injury [1-2]. As a metallotherapeutic 
agent, zinc possesses various pharmacological activities include 
fertility enhancing, retino-protective, and putative antiviral 
activities [3]. Zinc is also used in the treatment of Wilson’s 
disease [4]. It has also immunomodulatory and antioxidant 
activities [1]. Zinc is also used to prevent the development of 
several deficiency symptoms include parakeratosis, hypogeusia, 
anorexia, dysosmia, geophagia, hypogonadism, growth 
retardation, etc. [5-7]. Recently, it has been reported that zinc 
had increased the leukocyte count and phagocytic index, which 
potentiate the immunomodulatory effect along with Glycyrrhiza 
glabra [8]. Zinc chloride (ZnCl2) is hygroscopic inorganic salt 
and highly soluble in water [9]. It is sometimes used in 
pharmaceutical industry as drug and diagnostic agent due to its 
powerful astringent and mild antiseptic properties [10]. It is also 
used in mouth-wash and deodorant preparations. Zinc chloride is 
used in as dentin desensitizer i.e. reduces the sensitivity of the 
teeth to heat and cold. The other applications of zinc chloride 
include protein precipitation and insulin preparation [10, 11]. 
Literature reported that zinc chloride has been used in the 
treatment of cancer as a destructive agent [12] and in the 
pluripotency maintenance of mouse embryonic stem cell 
through the regulation of STAT3 signaling pathway [13]. It can 
be used for the palliative treatment of canine and malignant skin 
wounds [14]. It has the opposite effect on locomotor behavior of 
rats [15]. Therefore, zinc chloride was considered as one of the 
component in the novel proprietary herbomineral formulation 
for the source of zinc ion. This herbomineral formulation is 
designed as nutraceutical supplement, and can be used for the 
prevention and treatment of various human disorders. 
An élan vital or vital force which contributes the ‘life’ is 
preserved by every living organisms and known as prana by the 
Hindus, qi or chi by the Chinese, and ki by the Japanese. This is 
believed to co-relate with the soul, spirit and mind. This 
hypothetical vital force is considered as the Biofield Energy. The 
Biofield Energy is infinite, paradimensional and dynamic 
electromagnetic field surrounding the human body. It can freely 
flow between the human and environment that leads to the 
continuous movement or matter of energy [16, 17]. Thus, a 
human has the ability to harness energy from the earth, the 
“universal energy field” and transmit it to any living or 
nonliving object(s) around the globe. The objects always receive 
the energy and respond in a useful way. This process is known 
as Biofield Energy Healing Treatment [18, 19]. Biofield 
(Putative Energy Fields) based Energy Therapies are used 
worldwide to promote health and healing. The National Center 
of Complementary and Integrative Health (NCCIH) has been 
recognized and accepted Biofield Energy Healing as a 
Complementary and Alternative Medicine (CAM) health care 
approach in addition to other therapies, medicines and practices 
such as natural products, deep breathing, yoga, Tai Chi, Qi 
Gong, chiropractic/osteopathic manipulation, meditation, 
massage, special diets, homeopathy, progressive relaxation, 
guided imagery, acupressure, acupuncture, relaxation 
techniques, hypnotherapy, healing touch, movement therapy, 
pilates, rolfing structural integration, mindfulness, Ayurvedic 
medicine, traditional Chinese herbs and medicines, naturopathy, 
essential oils, aromatherapy, Reiki, cranial sacral therapy and 
applied prayer (as is common in all religions, like Christianity, 
Hinduism, Buddhism and Judaism) [20]. Biofield Energy 
Treatment (The Trivedi Effect®) has been reported in numerous 
peer-reviewed science journals with significant outcomes in 
many scientific fields such as cancer research [21]; altered 
antimicrobial sensitivity of pathogenic microbes in microbiology 
[22-24], biotechnology [25, 26], genetics [27, 28]; changing the 
structure of the atom in relation to various metals, ceramics, 
polymers and chemicals in materials science [29, 30], altered 
physical and chemical properties of pharmaceuticals [31, 32], 
nutraceuticals [33, 34], organic compounds [35-37], and 
improved overall growth and yield of plants in agricultural 
science [38, 39]. The physicochemical properties such as 
particle size, crystalline structure, crystallite size, surface area, 
and thermal properties of a drug have a vital role in 
bioavailability as well as stability of the drug during processing, 
formulation, storage, and packaging [40, 41]. The particle size, 
specific surface area, crystalline nature, chemical and thermal 
behavior of an atom/ion might be altered by the Biofield Energy 
Healing Treatment (The Trivedi Effect®) through possible 
mediation of neutrinos [42]. By considering all these aspects, 
powder X-ray diffraction (PXRD), particle size distribution 
analysis (PSD), Fourier transform infrared (FT-IR) 
spectrometry, ultraviolet-visible (UV-vis) spectroscopy, and 
differential scanning calorimetry (DSC) analytical techniques 
were conducted in this study for the characterization of physical, 
structural, and thermal properties of the Biofield Energy Treated 
and untreated zinc chloride. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Zinc chloride was procured from Tokyo Chemical Industry 
Co., Ltd. (TCI), Japan. All other chemicals used in the 
experiment were of analytical grade available in India. 
2.2. The Trivedi Effect
®
 - Energy of Consciousness Healing 
Treatment Strategies 
Zinc chloride was one of the components of the new 
proprietary herbomineral formulation, developed by our 
research team and it was used per se as the test compound for 
the current study. The test compound was divided into two 
parts, one part of the test compound did not receive any sort 
of treatment and was defined as the untreated or control zinc 
chloride sample. The second part of the test compound was 
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treated with The Trivedi Effect® - Energy of Consciousness 
Healing Treatment (Biofield Energy Treatment) by a group 
of seven renowned Biofield Energy Healers remotely and 
was denoted as Biofield Energy Treated or The Trivedi 
Effect® sample. Six Biofield Energy Healers were remotely 
located in the U.S.A. and one of which was remotely located 
in Canada, while the test compound was located in the 
research laboratory of GVK Biosciences Pvt. Ltd., 
Hyderabad, India. This Biofield Energy Treatment was 
provided for 5 minutes through Healer’s Unique Energy 
Transmission process remotely to the test compound under 
the laboratory conditions. None of the Biofield Energy 
Healers in this study visited the laboratory in person, nor had 
any contact with the compounds. Similarly, the control 
compound was subjected to “sham” healers for 5 minutes, 
under the same laboratory conditions. The sham healer did 
not have any knowledge about the Biofield Energy 
Treatment. After that, the Biofield Energy Treated and 
untreated samples were kept in similar sealed conditions and 
characterized thoroughly by PXRD, PSD, FT-IR, UV-visible 
spectroscopy, and DSC analysis.  
2.3. Characterization 
2.3.1. Powder X-Ray Diffraction (PXRD) Analysis 
The PXRD analysis was accomplished on PANalytical 
X’pert Pro powder X-ray diffractometer system. The X-ray 
of wavelength 1.54056 Å was used. The data was collected in 
the form of a chart of the Bragg angle (2θ) vs. intensity, and a 
detailed table containing information on peak intensity 
counts, d value (Å), relative intensity (%), full width half 
maximum (FWHM) (θ°). From the PXRD results, the 
crystallite size (G) was calculated using X’pert data collector 
and X’pert high score plus processing software. The 
crystallite size (G) was calculated from the Scherrer equation 
[43, 44]. The method was based on the width of the 
diffraction patterns obtained in the X-ray reflected the 
crystalline region. The crystallite size (G) was calculated by 
using the following formula (1): 
G = kλ/(bCosθ)                                 (1) 
Where, k is the equipment constant (0.5), λ is the X-ray 
wavelength (0.154 nm); b in radians is the full-width at half 
of the peaks and θ the corresponding Bragg angle. 
Percent change in crystallite size (G) was calculated using 
following equation (2): 
%	change	in	crystallite	size	 =
		
	
× 100  (2) 
Where, GControl and GTreated are the crystallite size of the 
control and Biofield Energy Treated samples, respectively. 
A total of ~500.21 mg of the control and treated samples 
individually were used for the analysis and prepared by back 
loading technique using the sample preparation kit. The 
sample was spread on the holder ring in sufficient quantity to 
fill the ring cavity. It was then pressed down using powder 
press block and scrap the powder that was in surplus using a 
glass slide to get densely packed specimen. Consequently, the 
bottom plate was placed onto the holder ring and clamp in 
position. The sample holder was then removed from the 
sample preparation table by turning it upside down. A 
smooth surface of sample was obtained to ensure optimum 
results. 
2.3.2. Particle Size Distribution (PSD) Analysis 
The average particle size and particle size distribution were 
analyzed using Malvern Mastersizer 2000, UK with a detection 
range between 0.01 µm to 3000 µm. The sample unit was filled 
with the dispersant medium and operated the stirrer at 2500 rpm. 
Alignment of the optics was done and the background 
measurement was taken. After the background measurement, the 
sample was added into the sample unit with constant monitoring 
the obscuration and stopped the addition of sample when the 
obscuration reached in between 15% to 20%. When the 
obscuration was stable, the measurement was taken twice and the 
average of two measurements was taken. The average histogram 
of the two measurements was recorded. The print out of the 
average histogram of the two measurements was documented. 
Along with histogram, the data was presented in table format 
which include particle size (µm). Also, the values at below 10% 
level (d10), 50% level (d50), and 90% level (d90) were calculated 
from the histogram and the calculations such as surface area 
(m2/g) were done by using software Mastersizer 2000. 
Percent change in particle size (d) for at below 10% level 
(d10), 50% level (d50), and 90% level (d90) was calculated 
using following equation (3): 
%	change	in	particle	size =
##
#
× 100     (3) 
Where, dControl and dTreated are the particle size (µm) for at 
below 10% level (d10), 50% level (d50), and 90% level (d90) 
of the control and treated samples, respectively. 
Percent change in surface area (S) was calculated using 
following equation (4): 
%	change	in	surface	area =
&	&	
&	
× 100	    (4) 
Where, SControl and STreated are the surface area of the 
control and treated samples, respectively. 
2.3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
FT-IR spectroscopy of zinc chloride was performed on 
Spectrum two (Perkin Elmer, USA) Fourier transform 
infrared spectrometer with the frequency array of 400-4000 
cm-1 by using pressed KBr disk technique. 
2.3.4. Ultraviolet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-Vis spectral analysis was carried out using Shimadzu 
UV-2450 with UV Probe, Japan. The spectrum was recorded 
using 1 cm quartz cell that has a slit width of 1.0 nm. The 
wavelength range chosen for recording the spectra was 190-800 
nm. The absorbance spectra (in the range of 0.2 to 0.9) and 
wavelength of maximum absorbance (λmax) were recorded. 
2.3.5. Differential Scanning Calorimetry (DSC) 
Analysis was performed using the DSC Q20 (TA 
Instruments, USA) differential scanning calorimeter. A total 
of ~7.50 mg sample was weighed and sealed in aluminum 
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pans and equilibrated at 25°C and heated up to 450ºC at the 
heating rate of 10°C/min under nitrogen gas as purge 
atmosphere with flow rate of 50 mL/min. The value for 
onset, endset, peak temperature, peak height (mJ or mW), 
peak area, and change in heat (J/g) for each peak were 
recorded. 
Percent change in the decomposition temperature (T) was 
calculated using following equation (5): 
%	change	in	melting	point 
))
)
 100     (5) 
Where, TControl and TTreated are the decomposition 
temperature of the control and treated samples, respectively. 
Percent change in the enthalpy of decomposition (∆H) was 
calculated using following equation (6): 
%	change	in	enthalpy	of	decomposition 
∆,-,
-,
 100                            (6) 
Where, ∆HControl and ∆HTreated are the enthalpy of decomposition of the control and treated samples, respectively. 
3. Results and Discussion 
3.1. Powder X-Ray Diffraction (PXRD) Analysis 
The PXRD diffractograms of both the control and 
treated zinc chloride are shown in the Figure 1. The 
diffractograms displayed very sharp and intense peaks in 
their respective diffractogram indicating the crystalline 
nature of zinc chloride. PXRD data such as Bragg angle 
(2θ), relative intensity (%), full width half maximum 
(FWHM) (θ°), and crystallite size (G) for the control and 
Biofield Energy Treated zinc chloride are presented in the 
Table 1. The crystallite size was calculated with the help 
of Scherrer equation [43, 44]. The crystallite size of the 
control and Biofield Energy Treated samples were found 
similar at 2θ equal to nearly 15.7°, 16.7°, 35.0°, 52.4°, and 
57.5° (Table 1, entry 1, 2, 5, 10, and 12). Consequently, 
the crystallite size of the Biofield Energy Treated zinc 
chloride at 2θ equal to nearly 25.5°, 29.4°, 38.4°, 49.3°, 
73.0°, 79.0°, 90.9°, and 92.0° (Table 1, entry 3, 4, 6, 8, 
and 17-20) was significantly increased in the range of 
20% to 50% compared with the control sample. On the 
other hand, the crystallite size of the treated zinc chloride 
at 2θ equal to nearly 48.8°, 56.3°, 58.4°, 61.9°, 63.3°, and 
70.7° (Table 1, entry 7, 11, and 13-16) was significantly 
decreased in the range of 20% to 50% with respect to the 
control sample. However, the average crystallite size of 
the Biofield Energy Treated sample was reduced by 2.13% 
(Table 1, entry 21) with respect to the control sample.  
 
Figure 1. PXRD diffractogram of the control and Biofield Energy Treated zinc chloride. 
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Table 1. PXRD data of the control and Biofield Energy Treated zinc chloride. 
Entry No. 
Bragg angle (°2θ) Relative Intensity (%) FWHM (°2θ) Crystallite size (G, nm) 
Control Treated  Control Treated  Control Treated  Control Treated  % change* 
1 15.72 15.65 22.72 59.13 0.1004 0.1004 44.26 44.25 -0.01 
2 16.73 16.64 20.47 19.67 0.0669 0.0669 66.50 66.49 -0.01 
3 25.55 25.48 72.86 81.57 0.1338 0.1004 33.73 44.95 33.25 
4 29.43 29.36 33.98 74.58 0.0669 0.0502 68.03 90.65 33.25 
5 35.03 34.98 85.14 50.04 0.0502 0.0502 91.96 91.95 -0.01 
6 38.39 38.32 77.55 39.85 0.0612 0.0502 76.17 92.85 21.89 
7 48.77 48.74 100.00 90.64 0.0612 0.1224 79.00 39.50 -50.01 
8 49.29 49.28 61.18 100.00 0.1020 0.0816 47.50 59.37 24.99 
9 51.45 Absent 16.46 NA 0.0816 NA 59.91 0.00 0.00 
10 52.40 52.32 20.50 20.21 0.0816 0.0816 60.15 60.13 -0.03 
11 56.33 56.25 31.27 27.35 0.0612 0.0816 81.63 61.20 -25.03 
12 57.51 57.46 11.60 21.17 0.0816 0.0816 61.57 61.56 -0.02 
13 58.38 58.39 26.87 26.04 0.0816 0.1020 61.83 49.47 -20.00 
14 61.86 61.82 9.17 34.06 0.0816 0.1020 62.93 50.34 -20.02 
15 63.28 63.22 9.14 32.93 0.0612 0.0816 84.55 63.39 -25.02 
16 70.67 72.20 28.61 41.77 0.0612 0.1020 88.26 53.47 -39.42 
17 72.28 73.89 19.55 19.14 0.1020 0.0816 53.50 67.58 26.32 
18 79.07 79.00 8.97 12.71 0.1020 0.0816 56.03 70.01 24.94 
19 90.86 90.84 8.68 11.94 0.1224 0.0816 51.35 77.01 49.97 
20 92.03 91.98 14.83 17.75 0.1224 0.1020 51.89 62.24 19.95 
21 Average crystallite size* 64.94 63.56 -2.13 
FWHM: Full width half maximum, *denotes the percentage change in the crystallite size of the Biofield Energy Treated sample with respect to the control 
sample. 
The PXRD diffractogram of the Biofield Energy Treated zinc 
chloride showed greater intensity at Bragg’s angle (2θ) equal to 
49.28° (Table 1, entry 8), whereas it was observed at 48.77° 
(Table 1, entry 7) in the control sample. A sharp peak at 2θ equal 
to 51.45° (Figure 1) was observed in the control sample, 
whereas this peak was absent in the treated sample. In addition, 
the XRD peaks at 2θ equal to 70.67° and 72.28° (Table 1, entry 
16 and 17) in the control sample were shifted to 72.20° and 
73.89° (Table 1, entry 16 and 17) in the treated sample. These 
results indicated the relative intensities of the XRD peaks (Table 
1) in the treated sample were significantly altered as compared 
to the control sample. It has been found in the scientific literature 
that XRD relative intensity of each diffraction face on the 
crystalline compound changes according to the crystal 
morphology [45]. Thus, it is presumed that the energy 
transferred through the Biofield Energy Healing Treatment 
probably altered the shape and size of molecules, which might 
be responsible for an alteration in the relative intensities and 
crystallite size in the treated sample as compared to the control 
sample. 
Raza et al. reported that changes in XRD pattern provide the 
proof of polymorphic transitions [46, 47]. Crystal habit, size, 
and even polymorphic form of a drug have a significant effect 
on the drug solubility, dissolution, and bioavailability. It has 
been reported in the literature that alteration in the crystal 
morphology had the significant impact on in vitro dissolution 
rate, with prospective for improving bioavailability [41]. Hence, 
PXRD study revealed that Biofield Energy Healing Treatment 
might introduced a new polymorphic form of zinc chloride, 
which could have improved bioavailability compared with the 
control sample. 
3.2. Particle Size Analysis 
The particle size data (d10, d50, and d90) of both the control and 
treated zinc chloride were investigated and the results are 
presented in the Table 2. 
Table 2. Particle size data (d10, d50, and d90) and surface area of the control 
and Biofield Energy Treated zinc chloride. 
Parameter d10 (µm) d50 (µm) d90 (µm) Surface area (m
2/g) 
Control 0.98 2.76 6.69 2.99 
Treated 0.95 2.54 5.92 3.16 
Percent 
change (%)* 
-3.06 -7.97 -11.51 5.69 
*denotes the percentage change in the particle size data (d10, d50, and d90) and 
surface area of the Biofield Energy Treated sample with respect to the 
control sample. 
It was evident that Biofield Energy Treatment (The Trivedi 
Effect® treated) has the ability to reduce the particle size (d10, 
d50, and d90) of zinc chloride with respect to the control 
sample. The size of the particles at below 10% level (d10), 
50% level (d50), and 90% level (d90) was decreased by 3.06%, 
7.97%, and 11.51%, respectively in the Biofield Energy 
Treated sample compared to the control sample. 
Particle size as well as the surface area have a major effect 
on dissolution of a compound in a solvent, because the 
surface energy influenced by surface area and chemical 
affinity is the driving factor for dissolution efficiency [48, 
49]. The surface area for both the control and Biofield 
Energy Treated zinc chloride samples was analyzed and the 
results are presented in Table 2. The control sample showed 
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surface area of 2.99 m2/g and it was increased to 3.16 m2/g in 
the Biofield Energy Treated zinc chloride. The result showed 
5.69% increase in surface area of the Biofield Energy Treated 
sample with respect to the control sample. 
Poorly crystallized compounds possess more surface area and 
higher exchange capacities than well-crystallized compounds 
[50]. In addition, the variation of the crystal morphology in the 
Biofield Energy Treated sample, which was well-supported from 
PXRD data, may cause to alter the surface area of the Biofield 
Energy Treated zinc chloride compared with the control sample. 
It has been well established that the particle size, shape and 
surface area of pharmaceutical compounds have an important 
impact on solubility, dissolution and in vivo bioavailability, as 
well as supports the designing of new drug delivery systems [51, 
52]. Reducing particle size and higher surface area would 
enhance the solubility of the solid particles, and consequently 
would increase the dissolution rate and bioavailability [53]. 
Thus, it is assumed that the Biofield Energy Treated zinc 
chloride might be dissolved and absorbed at a faster rate and 
may possibly have more bioavailability than untreated zinc 
chloride. 
 
 
3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
The FT-IR spectra of the control and Biofield Energy 
Treated samples of zinc chloride are presented in the Figure 
2. The characteristic peak were observed at 3496, 1616, 
1403, and 646 cm-1 in the control FT-IR spectrum (Figure 2). 
On the other hand, The FT-IR spectrum of the Biofield 
Energy Treated zinc chloride (Figure 2) showed the notable 
absorption bands at 3590 cm-1, 3519 cm-1, 1931 cm-1, 1608 
cm-1, 993 cm-1, and 505 cm-1. The strong and broad 
absorption band centered at 3496 cm-1 and the H-O-H 
bending motion at 1616 cm-1 that were due to the presence of 
the lattice water were found in the control FT-IR spectrum 
(Figure 2). Consequently, the peaks for the lattice water were 
observed in the spectrum of the Biofield Energy Treated zinc 
chloride (Figure 2) at 3590, 3519, and 1608 cm-1. From the 
literature, it has been found that metal stretching absorption 
band for inorganic materials was found in the 750-100 cm-1 
region [54]. In control spectrum, metal-halogen (Zn-Cl) 
stretching was shown at 646 cm-1, whereas it was shifted 
downward in the Biofield Energy Treated sample at 505 cm-1. 
Overall, FT-IR results suggest that there may be a significant 
impact of Biofield Energy Treatment on zinc chloride at the 
atomic level to reduce the force constant of Zn-Cl bonds. 
 
Figure 2. FT-IR spectra of the control and Biofield Energy Treated zinc chloride. 
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3.4. Ultraviolet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-visible spectra of both the control and treated zinc 
chloride are presented in the Figure 3. The wavelength of the 
most intense UV-Vis absorbance (λmax) of the both the 
control and Biofield Energy Treated samples were observed 
in their UV-Vis spectra (Figure 3) at 196.0 nm with a minor 
shift of absorbance maxima from 2.0317 (control) to 1.9653 
in the treated sample. The UV absorbance occurs due to the 
diverse type of energy transitions from the singlet to the 
singlet excited state such as σ→σ*, n→π*, and π→π*. These 
type of electronic transitions are occurred when the 
difference in energy between the lowest unoccupied 
molecular orbital (LUMO) and the highest occupied 
molecular orbital (HOMO) is significantly higher than the 
activation energy of the compound [55]. The UV-vis 
spectroscopic analysis of zinc chloride displayed no change 
in the λmax of the treated sample as compared to the control 
sample. Thus, the structural configuration or activation 
energy of the treated sample was not changed as compared to 
the control sample. 
3.5. Differential Scanning Calorimetry (DSC) Analysis 
The DSC thermograms of the control and treated zinc 
chloride are presented in the Figure 4. The 
melting/decomposition temperature and enthalpy of 
fusion/decomposition of the control and treated zinc chloride 
are presented in the Table 3. The melting/fusion temperature 
was increased by 0.93% in the treated zinc chloride 
(315.12°C) as compared to the control sample (312.23°C). 
The onset and endset melting temperatures of the treated 
sample were also increased by 2.50% and 0.62%, 
respectively compared with the control sample. The enthalpy 
of fusion (∆Hfusion) of the control and treated zinc chloride 
were 252.75 J/g and 338.27 J/g, respectively. The ∆Hfusion of 
the treated sample was increased significantly by 33.84% 
compared with the control sample. Similarly, the 
decomposition temperature of the treated zinc chloride 
(385.06°C) was increased by 0.56% compared to the control 
sample (382.90°C). The onset and endset decomposition 
temperatures of the treated sample were also increased by 
0.19% and 0.50%, respectively compared with the control 
sample. The enthalpy of decomposition (∆Hdecomposition) of the 
control and treated zinc chloride were 1173.25 J/g and 
1217.56 J/g, respectively. The ∆Hdecomposition of the treated 
sample was increased by 3.78% compared with the control 
sample. It is anticipated that Biofield Energy Treatment 
might enhance the internal energy in zinc chloride that leads 
to increase in the melting/decomposition temperature and the 
enthalpy of fusion/decomposition as well as thermal stability 
of the Biofield Energy Treated sample. The enhanced thermal 
stability of a drug is an advantage in the maintenance of the 
product in long term storage condition throughout the shelf-
life for any pharmaceutical formulations [56]. 
Table 3. The enthalpy of decomposition (J/g) and decomposition temperature (°C) values of the control and Biofield Energy Treated zinc chloride. 
Endothermic peak Description Tonset (°C) Tpeak (°C) Tendset (°C)  ∆H (J/g) 
 Control sample 297.34 312.23 317.13 252.75 
Endothermic peak Biofield Energy Treated sample 304.78 315.12 319.09 338.27 
% Change* 2.50 0.93 0.62 33.84 
 Control sample 378.91 382.90 385.25 1173.25 
Exothermic peak Biofield Energy Treated sample 379.63 385.06 387.19 1217.56 
% Change* 0.19 0.56 0.50 3.78 
Tonset: Onset decomposition temperature, Tpeak: Peak decompositi temperature, Tendset: Endset decomposition temperature, ∆H: Enthalpy of 
fusion/decomposition, adenotes the percentage change of the Biofield Energy Treated sample with respect to the control sample. 
 
Figure 3. UV-Vis spectra of the control and Biofield Energy Treated zinc chloride. 
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Figure 4. DSC thermograms of the control and Biofield Energy Treated zinc chloride. 
4. Conclusions 
The current study revealed that the Biofield Energy Healing 
Treatment (The Trivedi Effect®) had the notable effects on the 
physicochemical and thermal properties of zinc chloride. The 
PXRD data displayed the significant alteration of the crystallite 
size and relative intensities of the XRD peaks in The Trivedi 
Effect® sample compared with the control sample. A sharp peak 
at 2θ equal to 51.45°, which was found in the control sample 
was disappeared in the treated sample. The average crystallite 
size of the treated sample was decreased by 2.13% compared 
with the control sample. The size of the particles at d10, d50, and 
d90 values was decreased by 3.36%, 7.97%, and 11.51%, 
respectively in the treated sample compared with the control 
sample. The surface area of the treated sample was significantly 
increased by 5.69% compared with the control sample. The FT-
IR spectroscopic analysis revealed that Zn-Cl stretching 
vibration in the control sample was 646 cm-1, whereas it was 
significantly shifted downward to 505 cm-1in the treated sample. 
The DSC analysis exhibited that the melting and decomposition 
temperature were increased by 0.93% and 0.56%, respectively in 
the treated zinc chloride compared to the control sample. The 
enthalpy of fusion of the treated sample (338.27 J/g) was 
increased significantly by 33.84% compared with the control 
sample (252.75 J/g). The enthalpy of decomposition of the 
treated sample was increased by 3.78% compared with the 
control sample. The melting and decomposition temperature the 
treated zinc chloride were increased compared with the control 
sample. The DSC analysis exhibited that the treated zinc 
chloride was found to be thermally more stable compared with 
the control sample. Briefly, The Trivedi Effect® - Energy of 
Consciousness Healing Treatment might introduce a new 
thermally stable polymorphic form of zinc chloride that could be 
more soluble, bioavailable, and thermally stable compared with 
the untreated compound. The treated sample could be more 
stable during manufacturing, delivery or storage conditions than 
the untreated sample. Hence, the Biofield Energy Treated zinc 
chloride would be very useful to design better nutraceutical 
and/or pharmaceutical formulations that might offer better 
therapeutic response against inflammatory diseases, 
immunological disorders, aging, stress, cancer, Wilson’s disease, 
viral diseases, parakeratosis, hypogeusia, anorexia, dysosmia, 
geophagia, hypogonadism, growth retardation, etc. 
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